cytarabine has been researched along with Breast Cancer in 132 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 37 (28.03) | 18.7374 |
1990's | 26 (19.70) | 18.2507 |
2000's | 34 (25.76) | 29.6817 |
2010's | 27 (20.45) | 24.3611 |
2020's | 8 (6.06) | 2.80 |
Authors | Studies |
---|---|
Celewicz, L; Czarnecka, A; Hoffmann, M; Hładoń, B; Jóźwiak, A; Laskowska, H; Olejnik, A; Ruszkowski, P | 1 |
Bhaskaran Sathyabhama, A; Geethakumari, D; Mohandas, D; Raji Sathyan, K; Somasekharan, JV; Thavarool Puthiyedathu, S | 1 |
Gu, L; Liu, L; Luo, YH; Wu, HY | 1 |
Barrière, J; Bonneterre, J; Boulanger, T; Le Deley, MC; Le Rhun, E; Lorgis, V; Mailliez, A; Robin, YM; Rodrigues, I; Wallet, J; Weller, M | 1 |
Islam, S; Pal, S; Santra, MK; Sivakrishna, B | 1 |
Lee, EQ | 1 |
Andrews, C; Maze, D; Murphy, T; Sibai, H | 1 |
Dorn, J; Drecoll, E; Frejno, M; Heinzlmeir, S; Helm, D; Hogrebe, A; Kleigrewe, K; Kuster, B; Kvasnicka, HM; Meng, C; Mergner, J; Oellerich, T; Ruprecht, B; Samaras, P; Scheich, S; Serve, H; Weichert, W; Wilhelm, M; Zecha, J | 1 |
Gogia, B; Rai, P; Shivaprasad, A; Tremont-Lukats, IW | 1 |
Le Deley, MC; Le Rhun, E; Weller, M | 1 |
Agostoni, V; Couvreur, P; Gref, R; Lampropoulou, M; Lazarou, YG; Maksimenko, A; Rodriguez-Ruiz, V; Salzano, G; Yannakopoulou, K | 1 |
Guillaume, C; Lanotte, P; Le Brun, C; Pastuszka, A; Vegas, H | 1 |
Graham, C; Gralow, J; Johnson, N; Kim, B; Kurland, BF; Mrugala, MM; Sharma, A | 1 |
Akahane, D; Azuma, K; Katagiri, S; Ohyashiki, K; Saito, K | 1 |
André, C; Assaker, R; Baranzelli, MC; Bonneterre, J; Boulanger, T; Cazin, JL; Chamberlain, MC; Devos, P; Dubois, F; Kotecki, N; Le Rhun, E; Mailliez, A; Marliot, G; Servent, V; Taillibert, S; Vanlemmens, L; Vennin, P; Zairi, F | 1 |
Aittomäki, K; Blomqvist, C; Carpén, O; Fagerholm, R; Heikkilä, P; Heikkinen, T; Khan, S; Korpela, T; Nevanlinna, H | 1 |
Cui, J; Guo, R; Hoffman, AR; Hu, JF; Li, W; Sun, J; Wang, G; Wang, H | 1 |
Chan, HN; Ha, CY; Lai, HK; Law, MF; Leung, C; Ng, C; Yeung, YM; Yip, SF | 1 |
Bazhenova, L; Brown, BD; Brown, T; Carter, BS; Chen, CC; Fanta, P; Helsten, T; Kesari, S; Parker, B; Piccioni, DE; Pingle, S; Rush, T; Saria, MG; Schwab, R; Scott, BJ; van Vugt, VA | 1 |
Park, KY; Qiu, P | 1 |
Murawska, M; Niwińska, A; Rudnicka, H | 1 |
Jamaluddin, MA; Nalwa, A; Nath, D; Srivastava, A; Suri, V | 1 |
Aboukais, R; Assaker, R; Bertrand, N; Boulanger, T; Chamberlain, MC; Le Rhun, E; Taillibert, S; Zairi, F | 1 |
Ji, H; Liu, T; Nanding, A; Xuan, Q; Yan, C; Zhang, Q | 1 |
Amin, K; Barbarotta, L; Gore, SD; Kasberg, S; Kim, TK; Podoltsev, NA; Prebet, T; Roche, K; Stahl, M; Xu, ML; Zeidan, AM | 1 |
Anzalone, AA; Cajozzo, M; Fatica, F; Geraci, G; Modica, G | 1 |
Glas, M; Herrlinger, U; Rasch, K; Stuplich, M; Tschampa, H; Urbach, H | 1 |
Galmarini, CM; Kohli, E; Mitin, A; Vinogradov, SV; Warren, G; Zeman, A | 1 |
Enomoto, T; Hayashi, K; Iizuka, M; Kuranami, M; Nakakuma, T; Sengoku, N; Watanabe, M; Yoshimura, N | 1 |
Corsini, E; Erbetta, A; Gaviani, P; Salmaggi, A; Silvani, A | 1 |
Pan, IW; Shih, YC; Tsai, YW | 1 |
Chao, TY; Huang, TC | 1 |
Buhk, JH; Hoffmann, AL; Strik, H | 1 |
Atkins, CD | 2 |
Amano, S; Enomoto, K; Sakurai, K | 1 |
Hu, W; Li, L; Sheng, Y; Shi, J; Su, D; Wang, CK | 1 |
Liskova, S; Mardiak, J; Mego, M; Obertova, J; Palacka, P; Porsok, S; Rajec, J; Sycova-Mila, Z | 1 |
Adrada, BE; Carkaci, S; Whitman, GJ | 1 |
Chen, S; Fu, R; Gu, H; Li, Q; Wang, Y; Wu, H; Yuan, K; Zhang, K; Zhang, L | 1 |
Kucerova, L; Matuskova, M; Poturnajova, M; Tyciakova, S | 1 |
Bernard, PS; Cheang, MC; Chia, SK; Davies, S; Davis, C; Ebbert, MT; Ellis, MJ; Jiang, S; Leung, S; Levine, MN; Nielsen, TO; Parker, JS; Perou, CM; Pritchard, KI; Shepherd, LE; Stijleman, IJ; Tu, D; Voduc, KD | 1 |
Aiken, R; Baidas, S; Batchelor, T; Cohn, A; Fulton, D; Gilbert, M; Gutheil, JC; Heros, D; Howell, SB; Jaeckle, KA; Kennedy, JM; Lesser, G; Mason, W; Moots, P; New, P; O'Day, SJ; Phuphanich, S; Rogers, L; Russell, C; Swinnen, LJ; Wong, E | 1 |
Hada, M; Koshizuka, K; Muto, S; Nakagomi, H; Takano, K | 1 |
Bramwell, V; Crump, M; Levine, M; Pritchard, K; Shepherd, L; Tu, D | 1 |
Damon, L; Demirer, T; Derigs, G; Ferrante, P; Kröger, N; Rosti, G; Wandt, H; Zander, AR | 1 |
Chajek-Shaul, T; Cukierman, T; Ilsar, M; Liebster, D; Planer, D | 1 |
Deckert, M; Montesinos-Rongen, M; Pels, H; Schaller, C; Schlegel, U; Van Roost, D; Wiestler, OD | 1 |
Bjornsti, MA; de Jong, LA; Jansen, LE; Pluim, D; Schellens, JH; van Eijndhoven, MA; van Waardenburg, RC; Verseyden, C | 1 |
Ikeda, K; Matsumoto, K; Matsuoka, S; Ohta, M; Takeshita, I | 1 |
Miyahara, S; Mizutani, M; Murabayashi, K; Ogawa, T; Yabana, T | 1 |
Bell, C; Bighin, C; Boni, L; Catzeddu, T; Clavarezza, M; Del Mastro, L; Sertoli, MR; Testa, D; Venturini, M | 1 |
Ambrózay, E; Boross, G; Gyánti, R; Hajnal, L; Lorincz, M; Maráz, R; Markó, L; Svébis, M; Szucs, M; Vizhányó, R | 1 |
Jida, M; Kubo, M; Maeda, H; Miyatani, K; Mizuta, M; Shirakawa, K; Sogabe, O; Udaka, T; Yamane, M | 1 |
Bader, Y; Fritzer-Szekeres, M; Grusch, M; Hartmann, J; Krupitza, G; Leisser, C; Mader, RM; Madlener, S; Maier, S; Saiko, P; Sasgary, S; Schott, H; Strasser, S; Szekeres, T | 1 |
Bader, Y; Bernhaus, A; Fritzer-Szekeres, M; Gueorguieva, M; Krupitza, G; Leisser, C; Mader, RM; Madlener, S; Maier, S; Richter, S; Saiko, P; Schott, H; Strasser, S; Szekeres, T; Wesierska-Gadek, J | 1 |
Jensen, AB; Johansson, A; Mehlsen, M; Paulsen, K; von der Maase, H; Zachariae, R | 1 |
Andersen, J; Bergh, J; Cold, S; Edlund, P; Ejlertsen, B; Ewertz, M; Jensen, BB; Jensen, MB; Kamby, C; Mouridsen, HT; Nordenskjold, B | 1 |
Akçali, Z; Boğa, S; DemIrhan, B; Karakuş, S; Sahin, FI; Yilmaz, Z | 1 |
Colsky, J; Cummings, FJ; Gelman, R; Israel, L; Kuperminc, M; Skeel, RT; Tormey, D | 1 |
Ayus, C; Cook, G; Daskal, Y; Espada, R; Feldman, L; Frommer, P; Henry, JF; Howell, JF; Lehane, D; Mattioli, C; Miller, L; Shearer, WT; Terman, DS; Tillquist, R; Yamamoto, T; Young, JB; Zaleski, HI | 1 |
Carpenter, J; Fishkin, E; Krauss, S; Moore, MR; Raab, S; Raney, M; Smalley, RV; Stagg, M; Velez-Garcia, E; Vogel, CL | 1 |
Baguley, BC; Finlay, GJ | 1 |
Bartolucci, AA; Carpenter, J; Lefante, J; Marcial, V; Moore, M; Perez, CA; Smalley, RV; Velez-Garcia, E; Vogel, C; Wittliff, J | 1 |
Csoka, K; Larsson, R; Liliemark, J; Nygren, P | 1 |
Gurtler, J; Liebmann, J | 1 |
Amadori, D; Baldini, E; Brema, F; Gardin, G; Monzeglio, C; Naso, C; Pastorino, G; Pronzato, P; Rosso, R; Rubagotti, A | 1 |
Hapke, DM; Mitchell, BS; Stegmann, AP | 1 |
Bohr, VA; Cowans, KH; Parshad, R; Price, FM; Sanford, KK; Zujewski, JA | 1 |
Andreotti, PE; Bruckner, HW; Cree, IA; Dewar, JA; Hunter, EM; James, EA; Kurbacher, CM; Preece, PE; Subedi, AM; Sutherland, LA; Untch, M | 1 |
Boder, GB; Grindey, GB; Hertel, LW; Houghton, JA; Houghton, PJ; Merriman, RL; Rutherford, PG; Schultz, RM; Tanzer, LR | 1 |
Christensen, C; Deppe, G; Lawrence, WD; Ruan, H; Saunders, DE; Wappler, NL | 1 |
Chen, WD; Coxon, AB; Kaye, FJ; Khleif, SN; Lipkowitz, S; Otterson, GA | 1 |
Forman, SJ; Margolin, KA; Wright, C | 1 |
Czaykowski, PM; Oza, A; Samuels, T | 1 |
Berdel, WE; Bergmann, J; Brachwitz, H; Fichtner, I; Langen, P; Thomas, Y; Vollgraf, C | 1 |
Cole, KJ; Grover, PL; Martin, FL; Phillips, DH; Weaver, G | 1 |
Hanaoka, K; Hisaoka, M; Ikeda, T; Iwabuchi, H; Kaneko, M; Kobayashi, T; Kurakata, S; Matsuda, A; Mitsuhashi, Y; Miura, S; Nakagawa, A; Nomura, T; Sasaki, T; Shibayama, T; Suzuki, M; Tanaka, K; Tanzawa, F; Tomida, A; Tsuruo, T; Wataya, Y | 1 |
Belt, R; Coon, J; Cord, M; Dix, S; Geller, R; Howard, S | 1 |
Ennis, M; Goodwin, PJ; Hood, N; Pritchard, KI; Trudeau, M | 1 |
Chamberlain, MC; Cole, BF; Glantz, MJ; Howell, SB; Jaeckle, KA; LaFollette, S; Maria, B; Phuphanich, S; Recht, L; Schumann, GB; Swinnen, LJ | 1 |
Alvarez, E; Buesa, JM; Corral, N; Estaban, E; Estrada, E; Fernández, JL; Lacave, AJ; Muñiz, I; Palacio, I; Vieitez, JM | 1 |
Abdel-Aziz, W; Hickey, RJ; Jiang, HY; Malkas, LH | 2 |
Clowes, C; Duarte, R; Pu, QQ; Wang, X | 2 |
Björkholm, M; Gruber, A; Hansson, M; Steingrimsdottir, H; Svensson, A | 1 |
Chen, HC; Fang, FM; Hsiung, CY; Hsu, HC; Huang, EY; Sun, LM; Wang, CJ; Wu, JM; Yeh, SA | 1 |
Esteva, FJ; Forman, AD; Holmes, FA; Hortobagyi, GN; Meyers, CA; Plunkett, W; Soh, LT | 1 |
Aiken, R; Akerley, W; Allen, J; Baidas, S; Batchelor, T; Bent, MJ; Campbell, T; Chamberlain, MC; Cohn, A; Fulton, D; Gertler, SZ; Gilbert, M; Glantz, MJ; Greenberg, HS; Gutheil, JC; Heros, D; Howell, SB; Jaeckle, KA; LaFollette, S; Lesser, G; Maria, B; Mason, W; Moots, P; New, P; O'Day, SJ; Phuphanich, S; Recht, L; Rogers, L; Russell, C; Shapiro, W; Swinnen, L; Wong, E | 1 |
Ackland, SP; Anton, A; Breitbach, GP; Colajori, E; Delfino, C; Efremidis, A; Ezzat, A; Fittipaldo, A; Kolaric, K; Lopez, M; Tursi, JM; Viaro, D | 1 |
Canavese, G; Cavallari, M; Del Mastro, L; Guenzi, M; Ricci, P; Sanguineti, G; Stevani, I; Venturini, M | 1 |
Baba, K; Fukuda, M; Matsuda, M; Matsuoka, Y; Miyayama, H; Nagao, K; Nishimura, R; Yamashita, H | 1 |
Durodola, JI | 1 |
Alberto, P; Brugarolas, A; Cavalli, F; Gangji, D; Hansen, HH; Rozencweig, M; Siegenthaler, P; Sylvester, R | 1 |
Baker, L; Hoogstraten, B; O'Bryan, RM; Salmon, S; Vaughn, C; Whitecar, J | 1 |
Schabel, FM | 1 |
Calabresi, P; Cummings, FJ; Hoovis, ML | 1 |
Cantillo, R; Jain, J; Singhakowinta, A; Vaitkevicius, VK | 1 |
Kondo, H; Nomura, Y; Yamagata, J | 1 |
Hellman, S; Little, JB; Nove, J; Piro, AJ; Weichselbaum, RR | 1 |
Hellman, S; Little, JB; Nove, JJ; Piro, AJ; Weichselbaum, RR | 1 |
Nakamura, M; Yamaguchi, T | 1 |
DePhilip, RM; Lieberman, I; Lynch, WE | 1 |
Broder, LE; Carbone, PP | 1 |
Bashir, RM; Foley, J; Gasecki, AP | 1 |
Hori, T; Kan, N; Kato, H; Kodama, H; Kudo, N; Mukaihara, S; Ogawa, H; Ohsumi, K; Takenaka, A; Yasumura, T | 1 |
Cersosimo, RJ | 1 |
Faraggi, D; Henderson, IC; Kalra, J; Korzun, AH; Moore, A; Oster, MW; Perry, M; Schilsky, RL; Wood, WC | 1 |
Carpen, M; Cohen, JS; Daly, PF; Myers, CE; Sandler, D; Zugmaier, G | 1 |
Boogerd, W; Moffie, D; Smets, LA | 1 |
Abe, M; Kufe, D | 1 |
Büchner, T; Essink, M; Hiddemann, W; Huhn, D; Jung, M; Koppensteiner, R; Marosi, L; Martin, T; Minar, E; Siegert, W | 1 |
Ota, K | 1 |
Giannone, L; Greco, FA; Hainsworth, JD | 1 |
Bourguignat, A; Eydoux, P; Floiras, JL; Le Doussal, V; Trassard, M; Turpin, F | 1 |
Merino Moreno, J; Núñez Olarte, JM; Ortega Núñez, A; Pastor Gómez-Cornejo, L; Picó Sambucety, JM | 1 |
Kufe, DW; Robbins, G; Spriggs, DR | 1 |
Adam, T; Heidemann, E; Kloeter, I; Schabet, M; Wiethölter, H | 1 |
Blumenschein, GR; Buzdar, AU; Feldman, LD | 1 |
Andrews, NC; Davis, HL; Madden, R; Rochlin, DB; Sedransk, N; Weiss, AJ; Wilson, WL | 1 |
Duttera, MJ; Geelhoed, GW; Graff, KS; Henderson, ES | 1 |
Carter, SK | 1 |
Hall, TC | 1 |
Cohen, SM; Greenspan, EM; Weiner, MJ | 1 |
Hobson, RW; Kingry, RL; Muir, RW | 1 |
Frei, E | 1 |
Goldie, JH; Price, LA | 1 |
Rall, DP | 1 |
Brodovsky, HS; Burke, PJ; Colsky, J; Edmonson, JH; Hall, TC; Owens, AH; Schilling, A; Shnider, BI; Wallace, HJ | 1 |
8 review(s) available for cytarabine and Breast Cancer
Article | Year |
---|---|
Combination treatment with CPX-351 and midostaurin in patients with secondary acute myeloid leukaemia that are FLT3 mutated: three cases and review of literature.
Topics: Aged; Allografts; Anemia, Refractory, with Excess of Blasts; Aniline Compounds; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Clinical Trials, Phase III as Topic; Cytarabine; Daunorubicin; Fatal Outcome; Female; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Liposomes; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasm, Residual; Neoplasms, Radiation-Induced; Oncogene Proteins, Fusion; Peripheral Blood Stem Cell Transplantation; Point Mutation; Protein Kinase Inhibitors; Pyrazines; Remission Induction; Salvage Therapy; Staurosporine; Sulfonamides | 2020 |
Burkitt-like post-transplant lymphoproliferative disorder (PTLD) presenting with breast mass in a renal transplant recipient: a report of a rare case.
Topics: Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Immunophenotyping; Kidney Transplantation; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Postoperative Complications; Remission Induction; Vincristine | 2014 |
Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Epirubicin; Female; Humans; Incidence; Leukemia, Myeloid; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Leukemia, Radiation-Induced; Lymphatic Metastasis; Melphalan; Middle Aged; Mitoxantrone; Neoplasms, Second Primary; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Radiotherapy, Adjuvant; Thiotepa; Transplantation Conditioning; Transplantation, Autologous | 2003 |
Rationale for adjuvant chemotherapy.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carmustine; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Female; Floxuridine; Fluorouracil; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental | 1977 |
Leptomeningeal carcinomatosis: a report of 3 cases and review of the literature.
Topics: Adult; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Small Cell; Cytarabine; Diagnosis, Differential; Female; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Methotrexate; Middle Aged; Myelography; Prednisone; Vincristine | 1992 |
Idarubicin: an anthracycline antineoplastic agent.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Breast Neoplasms; Cytarabine; Drug Labeling; Humans; Idarubicin; Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphoma; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1992 |
An overview of the status of the nitrosoureas in other tumors.
Topics: Adenocarcinoma; Alkylating Agents; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Carcinoma, Bronchogenic; Carmustine; Cyclohexanes; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Hodgkin Disease; Humans; Hydroxyurea; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Melanoma; Melphalan; Multiple Myeloma; Nitrosourea Compounds; Prednisone; Vincristine | 1973 |
Predictive tests in cancer. Tuesday 9 April 1974.
Topics: Age Factors; Breast Neoplasms; Cell Movement; Clinical Enzyme Tests; Colonic Neoplasms; Cytarabine; Diagnosis, Differential; Doxorubicin; Drug Combinations; Drug Evaluation; Drug Evaluation, Preclinical; Fluorouracil; Humans; Kinetics; Leukemia; Mercaptopurine; Methods; Methotrexate; Models, Chemical; Neoplasms; Prognosis; Sarcoma; Testosterone; Thioguanine | 1974 |
23 trial(s) available for cytarabine and Breast Cancer
Article | Year |
---|---|
Intrathecal liposomal cytarabine plus systemic therapy versus systemic chemotherapy alone for newly diagnosed leptomeningeal metastasis from breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cytarabine; Humans; Injections, Spinal; Meningeal Carcinomatosis; Quality of Life | 2020 |
Phase II Study of Systemic High-dose Methotrexate and Intrathecal Liposomal Cytarabine for Treatment of Leptomeningeal Carcinomatosis From Breast Cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Injections, Spinal; Liposomes; Meningeal Carcinomatosis; Methotrexate; Middle Aged; Progression-Free Survival; Survival Rate | 2019 |
Clinical study of adjuvant capecitabine monotherapy in Chinese elderly patients (aged 55-70) with stage IIa breast cancer.
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; China; Cyclophosphamide; Cytarabine; Deoxycytidine; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Staging; Treatment Outcome | 2010 |
Responsiveness of intrinsic subtypes to adjuvant anthracycline substitution in the NCIC.CTG MA.5 randomized trial.
Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Methotrexate; Receptor, ErbB-2 | 2012 |
An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Breast Neoplasms; Cytarabine; Delayed-Action Preparations; Disease Progression; Female; Humans; Injections, Spinal; Male; Meningeal Neoplasms; Middle Aged; Survival Analysis | 2002 |
Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients.
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Epirubicin; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Menopause; Menopause, Premature; Menstrual Cycle; Middle Aged; Ovary; Premenopause; Prospective Studies | 2006 |
Improved outcome from substituting methotrexate with epirubicin: results from a randomised comparison of CMF versus CEF in patients with primary breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Epirubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Treatment Outcome | 2007 |
Phase II trials of Baker's antifol, bleomycin, CCNU, streptozotocin, tilorone, and 5-fluorodeoxyuridine plus arabinosyl cytosine in metastatic breast cancer.
Topics: Antineoplastic Agents; Bleomycin; Breast Neoplasms; Cytarabine; Drug Evaluation; Drug Therapy, Combination; Female; Floxuridine; Humans; Lomustine; Probability; Streptozocin; Tilorone; Triazines | 1981 |
Randomized trial of cyclophosphamide, doxorubicin, and 5-fluorouracil alone or alternating with a "cycle active" non-cross-resistant combination in women with visceral metastatic breast cancer: a Southeastern Cancer Study Group project.
Topics: Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Drug Resistance; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Methotrexate; Nausea; Random Allocation; Thrombocytopenia; Vincristine; Vomiting | 1984 |
Southeastern Cancer Study Group: breast cancer studies 1972-1982.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Postoperative Care; Prednisone; Time Factors; United States; Vincristine | 1983 |
Stimulation of human breast cancer in vivo. Experimental findings and clinical results.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Diethylstilbestrol; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Neoplasm Metastasis; Neoplasm Staging | 1993 |
Correlation of the clinical response to chemotherapy in breast cancer with ex vivo chemosensitivity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Resistance, Neoplasm; Epirubicin; Female; Humans; Prednisolone; Prognosis; Tumor Cells, Cultured; Vincristine | 1996 |
A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cytarabine; Delayed-Action Preparations; Disease Progression; Female; Humans; Injections, Spinal; Lung Neoplasms; Male; Melanoma; Meningeal Neoplasms; Methotrexate; Middle Aged; Neoplasms; Prospective Studies; Survival Rate; Survivors | 1999 |
Phase III trial of cyclophosphamide, epirubicin, fluorouracil (CEF) versus cyclophosphamide, mitoxantrone, fluorouracil (CNF) in women with metastatic breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Electrocardiography; Epirubicin; Female; Fluorouracil; Humans; Karnofsky Performance Status; Middle Aged; Mitoxantrone; Prospective Studies; Spain; Survival Analysis; Treatment Outcome | 1999 |
Multivariate analysis of pulmonary fibrosis after electron beam irradiation for postmastectomy chest wall and regional lymphatics: evidence for non-dosimetric factors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Chi-Square Distribution; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Radiation; Epirubicin; Female; Fluorouracil; Humans; Incidence; Logistic Models; Lymph Nodes; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoplasm Staging; Prospective Studies; Pulmonary Fibrosis; Radiation Dosage; Radiation Tolerance; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Risk Factors; Statistics, Nonparametric; Thorax | 2000 |
Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Arachnoiditis; Breast Neoplasms; Cohort Studies; Cytarabine; Delayed-Action Preparations; Female; Headache; Humans; Injections, Spinal; Meningeal Neoplasms; Middle Aged; Nausea; Survival Analysis; Treatment Outcome; Treatment Refusal; Vomiting | 2001 |
Dose-intensive epirubicin-based chemotherapy is superior to an intensive intravenous cyclophosphamide, methotrexate, and fluorouracil regimen in metastatic breast cancer: a randomized multinational study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Injections, Intravenous; Methotrexate; Middle Aged; Neoplasm Metastasis; Survival Analysis | 2001 |
Impact of chemotherapy dose-density on radiotherapy dose-intensity after breast conserving surgery.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Epirubicin; Female; Hematopoiesis; Humans; Mastectomy, Segmental; Middle Aged; Neoplasm Staging; Prognosis; Radiotherapy Dosage; Risk Factors | 2001 |
Phase II study of anhydro-ara-5-fluorocytidine in adenocarcinoma of gastrointestinal tract, epidermoid carcinoma of lung, head and neck, breast carcinoma and small cell anaplastic carcinoma of lung. A study report of the E.O.R.T.C. early clinical trial co
Topics: Ancitabine; Breast Neoplasms; Cytarabine; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Hematologic Diseases; Humans; Lung Neoplasms; Neoplasms | 1978 |
Cyclocytidine in breast cancer.
Topics: Ancitabine; Breast Neoplasms; Clinical Trials as Topic; Cytarabine; Female; Humans | 1978 |
[Intrapleural treatment of breast cancer patients with pleural effusions: an analysis of 13 institutes in Kyoto and Shiga Prefectures. Kyoto and Shiga Breast Cancer Study Group].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Doxorubicin; Drainage; Female; Humans; Immunotherapy, Adoptive; Lymphatic Metastasis; Lymphocytes, Tumor-Infiltrating; Middle Aged; Mitomycin; Multivariate Analysis; Picibanil; Pleural Effusion; Prognosis; Proportional Hazards Models; Retrospective Studies; Survival Rate | 1992 |
Cytosine arabinoside and cisplatin for advanced breast cancer. A phase II study of the Cancer and Leukemia Group B.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cytarabine; Drug Administration Schedule; Drug Evaluation; Female; Humans; Middle Aged; Prospective Studies; Survival Rate | 1991 |
Combination intraventricular chemotherapy for meningeal neoplasia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cytarabine; Female; Follow-Up Studies; Humans; Injections, Intraventricular; Lung Neoplasms; Lymphoma; Melanoma; Meningeal Neoplasms; Methotrexate; Thiotepa; Urinary Bladder Neoplasms | 1986 |
101 other study(ies) available for cytarabine and Breast Cancer
Article | Year |
---|---|
Synthesis and anticancer activity of 5'-chloromethylphosphonates of 3'-azido-3'-deoxythymidine (AZT).
Topics: Antineoplastic Agents; Biological Transport; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; Magnetic Resonance Spectroscopy; Molecular Structure; Mouth Neoplasms; Organophosphonates; Prodrugs; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet; Structure-Activity Relationship; Zidovudine | 2011 |
Folate functionalized chitosan nanoparticles as targeted delivery systems for improved anticancer efficiency of cytarabine in MCF-7 human breast cancer cell lines.
Topics: Breast Neoplasms; Cell Survival; Chitosan; Cytarabine; Drug Carriers; Drug Delivery Systems; Female; Folic Acid; Humans; MCF-7 Cells; Nanoparticles | 2022 |
Clinical characteristics and management of primary granulocytic sarcoma of the breast: A case report.
Topics: Adult; Breast Neoplasms; Cytarabine; Diagnosis, Differential; Female; Homoharringtonine; Humans; Induction Chemotherapy; Mastectomy, Modified Radical; Sarcoma, Myeloid; Sentinel Lymph Node Biopsy; Treatment Outcome | 2019 |
Synthesis and cytotoxic evaluation of apioarabinofuranosyl pyrimidines.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Colonic Neoplasms; Cytarabine; Female; Humans; MCF-7 Cells; Ovarian Neoplasms; Pyrimidines; Structure-Activity Relationship | 2020 |
To add IT chemotherapy, or not to add, that is the question.
Topics: Breast Neoplasms; Cytarabine; Drug Therapy, Combination; Humans | 2020 |
Proteome activity landscapes of tumor cell lines determine drug responses.
Topics: Adenylate Kinase; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Computational Biology; Computer Simulation; Cytarabine; Drug Development; Genomics; Humans; Leukemia, Myeloid, Acute; Neoplasms; Proteome; Proteomics; Raloxifene Hydrochloride; Receptors, Progesterone; Signal Transduction | 2020 |
DEPOSEIN: Take with a grain of salt.
Topics: Breast Neoplasms; Cytarabine; Humans | 2020 |
DEPOSEIN-how meaningful was the benefit from intrathecal chemotherapy?
Topics: Breast Neoplasms; Cytarabine; Humans; Meningeal Neoplasms | 2020 |
Positively charged cyclodextrins as effective molecular transporters of active phosphorylated forms of gemcitabine into cancer cells.
Topics: Antimetabolites, Antineoplastic; Biological Transport; Breast Neoplasms; Cyclodextrins; Cytarabine; Deoxycytidine; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Lymphoma, T-Cell; Models, Theoretical; Phosphorylation; Tumor Cells, Cultured | 2017 |
[Cerebrospinal fluid examination after liposomal cytarabine intrathecal injection].
Topics: Adult; Antimetabolites, Antineoplastic; Artifacts; Breast Neoplasms; Cerebrospinal Fluid; Cytarabine; Female; Humans; Injections, Spinal; Leukocytes; Liposomes; Meningeal Neoplasms | 2018 |
A unique breast involvement detected by MRI-DWIBS in T cell acute lymphoblastic leukemia.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Examination; Breast Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Diffusion Magnetic Resonance Imaging; Doxorubicin; Drug Monitoring; Female; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome; Vincristine; Whole Body Imaging | 2019 |
A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Cytarabine; Disease-Free Survival; Female; Humans; Injections, Spinal; Kaplan-Meier Estimate; Liposomes; Meningeal Carcinomatosis; Middle Aged; Proportional Hazards Models; Retrospective Studies | 2013 |
Eukaryotic translation initiation factor 4E (eIF4E) expression is associated with breast cancer tumor phenotype and predicts survival after anthracycline chemotherapy treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Eukaryotic Initiation Factor-4E; Female; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Proteins; Paraffin Embedding; Phenotype; Prognosis; Protein Biosynthesis; Tissue Array Analysis; Treatment Outcome; Triple Negative Breast Neoplasms | 2013 |
An intragenic long noncoding RNA interacts epigenetically with the RUNX1 promoter and enhancer chromatin DNA in hematopoietic malignancies.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Chromatin; Chromosome Aberrations; Chromosomes; Core Binding Factor Alpha 2 Subunit; Cytarabine; DNA; Enhancer Elements, Genetic; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Exome; Gene Expression Regulation, Leukemic; HeLa Cells; Hematologic Neoplasms; Humans; K562 Cells; Leukemia, Myeloid, Acute; Mutation; Polycomb Repressive Complex 2; Promoter Regions, Genetic; RNA, Long Noncoding; Translocation, Genetic | 2014 |
Concurrent intrathecal methotrexate and liposomal cytarabine for leptomeningeal metastasis from solid tumors: a retrospective cohort study.
Topics: Adult; Age Factors; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cytarabine; Disease-Free Survival; Feasibility Studies; Humans; Injections, Spinal; Kaplan-Meier Estimate; Karnofsky Performance Status; Liposomes; Lung Neoplasms; Meningeal Carcinomatosis; Methotrexate; Middle Aged; Retrospective Studies; Treatment Outcome | 2014 |
Model selection and diagnostics for joint modeling of survival and longitudinal data with crossing hazard rate functions.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Computer Simulation; Cyclophosphamide; Cytarabine; Epirubicin; Female; Fluorouracil; Humans; Life Tables; Longitudinal Studies; Methotrexate; Models, Statistical; Survival Analysis | 2014 |
Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Drug Administration Routes; Female; Humans; Injections, Spinal; Liposomes; Meningeal Neoplasms; Methotrexate; Middle Aged; Prospective Studies | 2015 |
Myeloid sarcoma of the breast in an aleukemic patient: a rare entity in an uncommon location.
Topics: Adult; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Biopsy; Breast Neoplasms; Cytarabine; Diagnosis, Differential; Diagnostic Errors; Female; Humans; Immunohistochemistry; Mammography; Mastectomy; Predictive Value of Tests; Sarcoma, Myeloid; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography, Mammary; Unnecessary Procedures | 2015 |
Complications related to the use of an intraventricular access device for the treatment of leptomeningeal metastases from solid tumor: a single centre experience in 112 patients.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Brain; Breast Neoplasms; Catheters, Indwelling; Cytarabine; Female; Follow-Up Studies; Humans; Injections, Intraventricular; Lung Neoplasms; Magnetic Resonance Imaging; Male; Melanoma; Meningeal Neoplasms; Middle Aged; Prospective Studies; Spinal Cord | 2015 |
The prognostic and predictive value of the lymphocyte to monocyte ratio in luminal-type breast cancer patients treated with CEF chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Lymphocyte Count; Lymphocytes; MCF-7 Cells; Middle Aged; Monocytes; Prognosis; Taxoids | 2016 |
Single agent blinatumumab as frontline therapy for an 85-year-old patient with B cell precursor acute lymphoblastic leukemia.
Topics: Aged, 80 and over; Antibodies, Bispecific; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Carcinoma, Transitional Cell; Cytarabine; Female; Humans; Lymphoma, B-Cell; Mercaptopurine; Methotrexate; Neoplasms, Second Primary; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Salvage Therapy; Urinary Bladder Neoplasms; Vincristine | 2016 |
Surgical treatment of solitary sternal metastasis from breast cancer Case report.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Epirubicin; Female; Fractures, Spontaneous; Humans; Middle Aged; Myocutaneous Flap; Pleura; Sternum | 2016 |
Liposomal cytarabine given concomitantly with radiotherapy in a patient with leptomeningeal metastasis from breast cancer.
Topics: Antimetabolites, Antineoplastic; Brain; Breast Neoplasms; Carcinoma; Cytarabine; Female; Humans; Liposomes; Meningeal Neoplasms; Middle Aged; Radiotherapy, Adjuvant | 2008 |
Polymeric nanogels containing the triphosphate form of cytotoxic nucleoside analogues show antitumor activity against breast and colorectal cancer cell lines.
Topics: Animals; Antineoplastic Agents; Arabinofuranosylcytosine Triphosphate; Breast Neoplasms; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Colorectal Neoplasms; Cytarabine; Deoxycytidine; Drug Carriers; Drug Screening Assays, Antitumor; Flow Cytometry; Gemcitabine; Humans; Mice; Nanogels; Nucleosides; Polyethylene Glycols; Polyethyleneimine; Polymers; Polyphosphates | 2008 |
[A case of stage IV breast cancer in which a long-term no change state (NC) was attained by a combination of S-1 and TAM following AC-T as a primary systemic therapy (PST)].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Combinations; Female; Humans; Mitoxantrone; Neoplasm Staging; Oxonic Acid; Paclitaxel; Tegafur; Time Factors; Tomography, X-Ray Computed; Topotecan | 2008 |
Neoplastic meningitis from breast carcinoma with complete response to liposomal cytarabine: case report.
Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Carcinoma; Cytarabine; Female; Humans; Injections, Spinal; Liposomes; Meningeal Carcinomatosis; Methotrexate; Middle Aged; Treatment Outcome | 2009 |
Information technology facilitates cost-effectiveness analysis in developing countries: an observational study of breast cancer chemotherapy in Taiwan.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Breast Neoplasms; Cost-Benefit Analysis; Cyclophosphamide; Cytarabine; Developing Countries; Economics, Pharmaceutical; Epirubicin; Female; Fluorouracil; Health Care Costs; Humans; Information Systems; Insurance Claim Reporting; Methotrexate; Models, Economic; National Health Programs; Policy Making; Taiwan | 2009 |
Mees lines and Beau lines after chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cytarabine; Daunorubicin; Docetaxel; Female; Humans; Leukemia, Myeloid, Acute; Nail Diseases; Taxoids | 2010 |
Neoplastic meningitis from breast cancer: feasibility and activity of long-term intrathecal liposomal Ara-C combined with dose-dense temozolomide.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Dacarbazine; Feasibility Studies; Female; Humans; Injections, Spinal; Liposomes; Meningeal Neoplasms; Temozolomide | 2009 |
Optimal chemotherapy for high-risk early-stage breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Humans; Maximum Tolerated Dose; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Prognosis; Risk Assessment; Survival Analysis; Treatment Outcome | 2010 |
Recovery of menstruation after long-term chemotherapy and endocrine therapy in pre-menopausal patients with breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Epirubicin; Female; Gonadotropin-Releasing Hormone; Humans; Menstruation; Middle Aged; Premenopause; Tamoxifen | 2011 |
Intrathecal administration of trastuzumab with cytarabine and methotrexate in breast cancer patients with leptomeningeal carcinomatosis.
Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cytarabine; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Injections, Spinal; Liver Neoplasms; Meningeal Carcinomatosis; Methotrexate; Neoplasm Metastasis; Receptor, ErbB-2; Trastuzumab; Treatment Outcome | 2011 |
Case of the season: Large B-cell lymphoma involving both breasts.
Topics: Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Cytarabine; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, B-Cell; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rituximab; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2011 |
Identification of potential markers related to neoadjuvant chemotherapy sensitivity of breast cancer by SELDI-TOF MS.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Pharmacological; Biomarkers, Tumor; Biopsy, Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Complement C3a; Cyclophosphamide; Cytarabine; Drug Resistance, Neoplasm; Epirubicin; Female; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Proteomics; Reproducibility of Results; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2012 |
Increased proliferation and chemosensitivity of human mesenchymal stromal cells expressing fusion yeast cytosine deaminase.
Topics: Adipose Tissue; Apoptosis; Azacitidine; Breast Neoplasms; Cell Death; Cell Line, Tumor; Cell Proliferation; Cytarabine; Cytosine Deaminase; Drug Screening Assays, Antitumor; Female; Fluorouracil; Genetic Engineering; Green Fluorescent Proteins; Humans; Mesenchymal Stem Cells; Recombinant Fusion Proteins; Retroviridae; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Transduction, Genetic; Transgenes | 2012 |
[Delivery of twins after undergoing adjuvant LHRH analogue and CEF therapy].
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Delivery, Obstetric; Epirubicin; Female; Gonadotropin-Releasing Hormone; Humans; Lymph Node Excision; Mastectomy, Segmental; Pregnancy; Tamoxifen; Twins | 2003 |
Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group.
Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Cytarabine; Epirubicin; Female; Fluorouracil; Humans; Leukemia; Methotrexate; Middle Aged; Neoplasms, Multiple Primary; Risk | 2003 |
Anterior uveitis as a complication of treatment with high dose cytosine-arabinoside.
Topics: Adult; Breast Neoplasms; Cytarabine; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Uveitis, Anterior | 2004 |
Clonal evolution as pathogenetic mechanism in relapse of primary CNS lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Base Sequence; Breast Neoplasms; Clone Cells; Combined Modality Therapy; Cytarabine; DNA, Neoplasm; Embryonal Carcinoma Stem Cells; Female; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Genes, Immunoglobulin; Germinal Center; Humans; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Methotrexate; Molecular Sequence Data; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neoplastic Stem Cells; Parietal Lobe; Remission Induction; Sequence Alignment; Sequence Homology, Nucleic Acid; Supratentorial Neoplasms; Temporal Lobe | 2004 |
Platinated DNA adducts enhance poisoning of DNA topoisomerase I by camptothecin.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Camptothecin; Cisplatin; Colonic Neoplasms; Cytarabine; DNA; DNA Adducts; DNA Topoisomerases, Type I; Drug Synergism; Enzyme Inhibitors; Female; Humans; Models, Molecular; Ovarian Neoplasms; Platinum Compounds; Topoisomerase I Inhibitors; Topotecan; Tumor Cells, Cultured | 2004 |
[Case of central nervous system lymphoma metastasized to breast after remission by methotrexate chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Cytarabine; Fatal Outcome; Female; Humans; Lymphoma, B-Cell; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Pulse Therapy, Drug; Radiotherapy, Adjuvant; Remission Induction; Vincristine | 2005 |
A Case of Burkitt's Lymphoma Involving Both Breasts.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Diagnostic Errors; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Lymphoma, B-Cell; Peripheral Blood Stem Cell Transplantation; Prednisone; Vincristine | 2005 |
[Response rates following neoadjuvant chemotherapy and breast preserving treatment in patients with locally advanced breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Cyclophosphamide; Cytarabine; Docetaxel; Epirubicin; Female; Humans; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Retrospective Studies; Taxoids; Treatment Outcome | 2005 |
[Improved quality of life in a patient with carcinomatous meningitis from invasive lobular carcinoma treated with intrathecal MTX and Ara-C in combination with systemic docetaxel].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Lobular; Cerebrospinal Fluid; Cytarabine; Docetaxel; Drug Administration Schedule; Female; Humans; Injections, Spinal; Meningeal Neoplasms; Meningitis; Methotrexate; Quality of Life; Taxoids | 2005 |
Analysis of mechanisms contributing to AraC-mediated chemoresistance and re-establishment of drug sensitivity by the novel heterodinucleoside phosphate 5-FdUrd-araC.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cytarabine; Drug Resistance, Neoplasm; Female; Floxuridine; Humans; Molecular Structure | 2006 |
5-FdUrd-araC heterodinucleoside re-establishes sensitivity in 5-FdUrd- and AraC-resistant MCF-7 breast cancer cells overexpressing ErbB2.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Breast Neoplasms; Caspase 7; Cell Cycle; Cell Proliferation; Cyclin D1; Cytarabine; Dimerization; Drug Resistance, Neoplasm; Female; Floxuridine; Humans; Receptor, ErbB-2; Tumor Cells, Cultured | 2006 |
Anticipatory nausea: the role of individual differences related to sensory perception and autonomic reactivity.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Arousal; Autonomic Nervous System; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Cytarabine; Epirubicin; Female; Fluorouracil; Humans; Individuality; Methotrexate; Middle Aged; Perception; Radiotherapy, Adjuvant; Sick Role; Statistics as Topic; Vomiting, Anticipatory | 2007 |
t(8;16) AML developed subsequent to breast cancer therapy.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Chromosomes, Human, Pair 16; Chromosomes, Human, Pair 8; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Estrogens; Fatal Outcome; Female; Fluorouracil; Humans; Idarubicin; Leukemia, Myelomonocytic, Acute; Mastectomy, Modified Radical; Middle Aged; Neoplasms, Hormone-Dependent; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Nitriles; Radiotherapy, Adjuvant; Translocation, Genetic; Triazoles | 2006 |
Preliminary observations of the effects on breast adenocarcinoma of plasma perfused over immobilized protein A.
Topics: Antigen-Antibody Complex; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cytarabine; Female; Follow-Up Studies; Hemoperfusion; Humans; Middle Aged; Plasma; Staphylococcal Protein A | 1981 |
The use of human cancer cell lines as a primary screening system for antineoplastic compounds.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line; Cell Survival; Colonic Neoplasms; Cytarabine; Drug Evaluation, Preclinical; Drug Resistance; Female; Fluorouracil; Humans; Leukemia; Methotrexate; Neoplasms | 1984 |
Evaluation of the cytotoxic activity of gemcitabine in primary cultures of tumor cells from patients with hematologic or solid tumors.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Cisplatin; Cladribine; Colorectal Neoplasms; Cytarabine; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; In Vitro Techniques; Leukemia; Lung Neoplasms; Lymphoma; Ribonucleotide Reductases; Tumor Cells, Cultured; Urogenital Neoplasms | 1995 |
Combination intraventricular therapy with thiotepa and cytarabine in meningeal carcinomatosis due to breast cancer: in vitro evidence for supra-additive cytotoxicity.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Drug Resistance; Drug Synergism; Female; Humans; Injections, Intraventricular; Meningeal Neoplasms; Middle Aged; Salvage Therapy; Thiotepa; Tumor Cells, Cultured | 1995 |
Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Biotransformation; Breast Neoplasms; Carcinoma, Small Cell; Cladribine; Colonic Neoplasms; Cytarabine; Deoxycytidine Kinase; DNA, Complementary; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Genetic Vectors; Humans; Lung Neoplasms; Moloney murine leukemia virus; Phosphorylation; Recombinant Fusion Proteins; Tumor Cells, Cultured; Vidarabine | 1996 |
Deficient DNA repair capacity, a predisposing factor in breast cancer.
Topics: Animals; Breast Neoplasms; CHO Cells; Chromatids; Cricetinae; Cytarabine; DNA Damage; DNA Repair; DNA, Neoplasm; Female; Humans; Lymphocyte Activation; Lymphocytes; Phytohemagglutinins; Risk Factors; Transfection; Ultraviolet Rays; X-Rays; Xeroderma Pigmentosum | 1996 |
Comparison of the antitumor activity of gemcitabine and ara-C in a panel of human breast, colon, lung and pancreatic xenograft models.
Topics: Animals; Antimetabolites, Antineoplastic; Breast Neoplasms; Colonic Neoplasms; Cytarabine; Deoxycytidine; Gemcitabine; Humans; Lung Neoplasms; Mice; Mice, Nude; Models, Biological; Molecular Structure; Pancreatic Neoplasms; Transplantation, Heterologous; Treatment Outcome | 1996 |
Paclitaxel-induced apoptosis in MCF-7 breast-cancer cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Caffeine; Cell Cycle; Cisplatin; Cytarabine; DNA Damage; DNA Fragmentation; DNA, Neoplasm; Doxorubicin; Estrogens; Female; Humans; Neoplasms, Hormone-Dependent; Paclitaxel; Tumor Cells, Cultured | 1997 |
Apoptosis is associated with cleavage of a 5 kDa fragment from RB which mimics dephosphorylation and modulates E2F binding.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carrier Proteins; Cell Cycle Proteins; Cysteine Endopeptidases; Cytarabine; DNA-Binding Proteins; E2F Transcription Factors; Etoposide; fas Receptor; Female; HL-60 Cells; Humans; Peptide Fragments; Phosphorylation; Retinoblastoma Protein; Retinoblastoma-Binding Protein 1; Transcription Factor DP1; Transcription Factors | 1997 |
Autologous bone marrow purging by in situ IL-2 activation of endogenous killer cells.
Topics: Bone Marrow Purging; Bone Marrow Transplantation; Breast Neoplasms; Colony-Forming Units Assay; Cytarabine; Cytotoxicity, Immunologic; Daunorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Hematopoietic Stem Cells; HL-60 Cells; Humans; Interleukin-2; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Leukemia; Lung Neoplasms; Lymphocyte Activation; Tissue Donors; Transplantation, Autologous; Transplantation, Homologous; Tumor Cells, Cultured | 1997 |
A durable response to cytarabine in advanced breast cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Lobular; Combined Modality Therapy; Cytarabine; Female; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Medication Errors; Middle Aged; Radiotherapy Dosage; Superior Vena Cava Syndrome | 1997 |
1-beta-D-Arabinofuranosylcytosine-5'-alkylphosphonophosphates and diphosphates: new orally active derivatives of ara-C.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Calcium; Cell Division; Cell Line; Cytarabine; Female; Humans; Leukemia P388; Mice; Molecular Structure; Phospholipid Ethers; Structure-Activity Relationship; Tumor Cells, Cultured | 1998 |
Adjuvant chemotherapy with CEF versus CMF for node-positive breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Proportional Hazards Models; Randomized Controlled Trials as Topic; Research Design | 1998 |
Genotoxicity of human milk extracts and detection of DNA damage in exfoliated cells recovered from breast milk.
Topics: Breast; Breast Neoplasms; Cells, Cultured; Cytarabine; DNA Damage; Dose-Response Relationship, Drug; Epithelial Cells; Female; Humans; Hydroxyurea; Micronucleus Tests; Milk, Human; Mutagenicity Tests; Mutagens; Pilot Projects; Ribosomal Protein S9; Ribosomal Proteins; Salmonella typhimurium; Time Factors | 1999 |
Antitumor activity and novel DNA-self-strand-breaking mechanism of CNDAC (1-(2-C-cyano-2-deoxy-beta-D-arabino-pentofuranosyl) cytosine) and its N4-palmitoyl derivative (CS-682).
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Arabinonucleosides; Biotransformation; Breast Neoplasms; Cisplatin; Cytarabine; Cytosine; Deoxycytidine; Deoxycytidine Kinase; DNA Damage; DNA, Neoplasm; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Fluorouracil; Humans; KB Cells; Leukemia P388; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Nude; Mitomycin; Molecular Structure; Neoplasm Proteins; Neoplasm Transplantation; Neoplasms, Experimental; Rats; Rats, Nude; Specific Pathogen-Free Organisms; Stomach Neoplasms; Tumor Cells, Cultured; Vincristine | 1999 |
Safety and efficacy of a continuous infusion, patient controlled anti-emetic pump to facilitate outpatient administration of high-dose chemotherapy.
Topics: Adult; Ambulatory Care; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Dexamethasone; Diphenhydramine; Etoposide; Evaluation Studies as Topic; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Infusion Pumps; Infusions, Intravenous; Lorazepam; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Nausea; Patient Acceptance of Health Care; Prospective Studies; Safety; Self Care; Thiotepa; Vomiting | 1999 |
Risk of menopause during the first year after breast cancer diagnosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Cytarabine; Epirubicin; Female; Fluorouracil; Humans; Mastectomy; Menopause, Premature; Methotrexate; Middle Aged; Multivariate Analysis; Premenopause; Probability; Risk Factors; Tamoxifen | 1999 |
Epirubicin regimen cuts risk of death in premenopausal women with early breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Epirubicin; Female; Humans; Premenopause; Survival Rate | 1999 |
Ara-C affects formation of cancer cell DNA synthesome replication intermediates.
Topics: Antigens, Polyomavirus Transforming; Antimetabolites, Antineoplastic; Arabinofuranosylcytosine Triphosphate; Breast Neoplasms; Cell Division; Cytarabine; DNA Polymerase I; DNA Polymerase III; DNA Replication; DNA, Neoplasm; Humans; Replicon; Tumor Cells, Cultured | 2000 |
Effects of gemcitabine and araC on in vitro DNA synthesis mediated by the human breast cell DNA synthesome.
Topics: Antigens, Polyomavirus Transforming; Antimetabolites, Antineoplastic; Arabinofuranosylcytosine Triphosphate; Breast Neoplasms; Cloning, Molecular; Cytarabine; Deoxycytidine; DNA Polymerase I; DNA Polymerase III; DNA, Neoplasm; Gemcitabine; Humans; Replicon; Tumor Cells, Cultured | 2000 |
Serum ICAM-1 concentrations following conventional dose consolidation chemotherapy for acute myeloid leukemia and after high dose chemotherapy with autologous haematopoietic stem cell rescue.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Breast Neoplasms; Combined Modality Therapy; Cytarabine; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Intercellular Adhesion Molecule-1; Leukemia, Myeloid; Leukocyte Count; Male; Middle Aged; Neoplasm Proteins; Neutropenia; Neutrophils; Recombinant Proteins; Solubility | 2000 |
Expression of CD11b/CD18 on neutrophils after consolidation chemotherapy for acute myeloid leukemia and after high dose chemotherapy with autologous haematopoietic stem cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Breast Neoplasms; CD18 Antigens; Combined Modality Therapy; Cytarabine; Etoposide; Female; Filgrastim; Gene Expression Regulation, Leukemic; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid; Macrophage-1 Antigen; Male; Melphalan; Middle Aged; Neoplasm Proteins; Neutropenia; Recombinant Proteins; Remission Induction | 2000 |
Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Breast Neoplasms; Carmustine; Cell Lineage; Combined Modality Therapy; Cytarabine; Disease Susceptibility; Female; Graft Survival; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infections; Lymphocyte Count; Lymphocyte Subsets; Lymphopenia; Male; Melphalan; Middle Aged; Podophyllotoxin; Sweden; Transplantation Conditioning; Transplantation, Autologous | 2000 |
Phase II trial and pharmacokinetic evaluation of cytosine arabinoside for leptomeningeal metastases from breast cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Breast Neoplasms; Cognition; Cytarabine; Female; Humans; Meningeal Neoplasms; Middle Aged; Survival Analysis; Treatment Outcome | 2000 |
An evaluation of predictive factors involved in clinical or pathological response to primary chemotherapy in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Breast Neoplasms; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Logistic Models; Mastectomy, Segmental; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Probability; Prognosis; Survival Rate; Treatment Outcome | 2002 |
Burkitt's lymphoma presenting during lactation.
Topics: Adolescent; Adult; Autopsy; Breast Diseases; Breast Neoplasms; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Female; Humans; Lactation; Male; Methotrexate; Pregnancy | 1976 |
Phase I study of 5-fluorodeoxyuridine plus cytosine arabinoside infusions in patients with solid tumors.
Topics: Adolescent; Adult; Aged; Breast Neoplasms; Cytarabine; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Female; Floxuridine; Head and Neck Neoplasms; Humans; Infusions, Parenteral; Male; Malignant Carcinoid Syndrome; Middle Aged; Neoplasms | 1979 |
Blindness as initial manifestation of meningeal carcinomatosis in breast cancer.
Topics: Blindness; Breast Neoplasms; Cytarabine; Female; Humans; Meningeal Neoplasms; Middle Aged | 1979 |
Significance of estrogen receptor assay in cytotoxic chemotherapy in relation to previous endocrine therapy of advanced breast cancer patients.
Topics: Adrenalectomy; Adult; Aged; Breast Neoplasms; Cytarabine; Doxorubicin; Female; Fluorouracil; Humans; Middle Aged; Mitomycins; Receptors, Estrogen | 1979 |
Combination hormonal, chemotherapy and radiotherapy in vitro: implications for therapy in vivo.
Topics: Breast Neoplasms; Cell Line; Cell Survival; Cytarabine; Drug Therapy, Combination; Estradiol; Female; Humans; Methotrexate; Neoplasms, Hormone-Dependent; Tamoxifen | 1979 |
Proliferation kinetics of a human breast cancer line in vitro following treatment with 17beta-estradiol and 1-beta-D-arabinofuranosylcytosine.
Topics: Breast Neoplasms; Cell Cycle; Cell Division; Cell Line; Cytarabine; Dose-Response Relationship, Drug; Drug Interactions; Estradiol; Female; Humans; Kinetics; Neoplasms, Experimental; Receptors, Estrogen | 1978 |
Combination therapy with mitomycin C, 5-fluorouracil, and cytosine arabinoside for nonresectable malignant tumor in man.
Topics: Adult; Aged; Bone Marrow; Breast Neoplasms; Cytarabine; Drug Therapy, Combination; Female; Fluorouracil; Humans; Male; Melena; Middle Aged; Mitomycins; Neoplasm Metastasis; Remission, Spontaneous; Stomach Neoplasms | 1978 |
Nuclear DNA polymerases of human carcinomas.
Topics: Animals; Breast Neoplasms; Cecal Neoplasms; Cecum; Cell Nucleus; Cytarabine; DNA-Directed DNA Polymerase; DNA, Neoplasm; Humans; Isoenzymes; Liver; Liver Regeneration; Lung; Lung Neoplasms; Neoplasms; Novobiocin; Nucleic Acid Synthesis Inhibitors; Rats | 1977 |
Pharmacokinetic considerations in the design of optimal chemotherapeutic regimens for the treatment of breast carcinoma: a comceptual approach.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Cytarabine; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fluorouracil; Humans; Injections, Intravenous; Methotrexate; Research Design; Vincristine | 1976 |
Regulation of the cytidine phospholipid pathways in human cancer cells and effects of 1-beta-D-arabinofuranosylcytosine: a noninvasive 31P nuclear magnetic resonance study.
Topics: Basement Membrane; Breast Neoplasms; Cytarabine; Humans; In Vitro Techniques; Lymphoma; Magnetic Resonance Spectroscopy; Nucleotidyltransferases; Phosphatidylcholines; Phosphatidylethanolamines; Phosphoric Diester Hydrolases; Tumor Cells, Cultured | 1990 |
Early blindness and coma during intrathecal chemotherapy for meningeal carcinomatosis.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Blindness; Breast Neoplasms; Coma; Cytarabine; Demyelinating Diseases; Female; Humans; Injections, Intraventricular; Meningeal Neoplasms; Methotrexate | 1990 |
Effects of maturational agents on expression and secretion of two partially characterized high molecular weight milk-related glycoproteins in MCF-7 breast carcinoma cells.
Topics: Antibodies, Monoclonal; Antigens, Neoplasm; Breast Neoplasms; Cell Differentiation; Cell Line; Cross Reactions; Cytarabine; Female; Glycoproteins; Humans; Methionine; Milk Proteins; Molecular Weight; Neuraminidase; Protein Biosynthesis; RNA; Tetradecanoylphorbol Acetate | 1986 |
Accidental overdose of mitoxantrone in three patients.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Small Cell; Cytarabine; Drug Overdose; Drug Tolerance; Female; Humans; Leukemia, Myeloid, Acute; Male; Mitoxantrone | 1989 |
[Continuous venous infusion in cancer chemotherapy].
Topics: Bleomycin; Bone Marrow; Breast Neoplasms; Cytarabine; Doxorubicin; Drug Administration Schedule; Fluorouracil; Heart; Humans; Infusions, Parenteral; Lung Neoplasms; Neoplasms | 1985 |
Mitoxantrone.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cytarabine; Daunorubicin; DNA; Drug Administration Schedule; Humans; Leukemia; Mitoxantrone | 1988 |
[An unusual way of manifesting acute granulocytic leukemia: granulocytic sarcoma of the breast. Apropos of a case with trisomy 22].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chromosomes, Human, 21-22 and Y; Cytarabine; Daunorubicin; Female; Granulocytes; Humans; Karyotyping; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Neoplasms, Multiple Primary; Trisomy | 1986 |
[Granulocytic sarcoma (chloroma) with bladder and breast localizations preceding acute myeloblastic leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Drug Combinations; Female; Humans; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Time Factors; Urinary Bladder Neoplasms; Vincristine | 1987 |
Effects of cis-diamminedichloroplatinum on DNA incorporation and cytotoxicity of 1-beta-D-arabinofuranosylcytosine.
Topics: Breast Neoplasms; Cell Survival; Cells, Cultured; Cisplatin; Cytarabine; DNA; DNA Damage; DNA Repair; Drug Interactions; Humans | 1986 |
Diagnosis and treatment of meningeal carcinomatosis in ten patients with breast cancer.
Topics: Adult; Brain; Breast Neoplasms; Carcinoma; Cerebrospinal Fluid; Cytarabine; Female; Humans; Meningeal Neoplasms; Methotrexate; Middle Aged; Tomography, X-Ray Computed | 1986 |
High-dose 1-beta-D-arabinofuranosylcytosine in advanced breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Cytarabine; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Hypotension; Middle Aged | 1985 |
Cytosine arabinoside (NSC 63878) toxicity and antitumor acitivity in human solid tumors.
Topics: Adenocarcinoma; Anemia; Blood Cell Count; Blood Platelets; Bone Neoplasms; Breast Neoplasms; Cytarabine; Dose-Response Relationship, Drug; Female; Gastrointestinal Neoplasms; Hemoglobinometry; Humans; Injections, Intravenous; Leukopenia; Male; Nausea; Sarcoma; Thrombocytopenia; Vomiting | 1974 |
Acute leukemia presenting as a breast mass.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Biopsy, Needle; Breast Neoplasms; Child; Cytarabine; Daunorubicin; Diagnosis, Differential; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Menarche; Mercaptopurine; Methotrexate; Prednisolone; Sulfates; Vincristine | 1973 |
1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given alone and combined with antimetabolites in the treatment of advanced solid tumors.
Topics: Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Cystadenoma; Cytarabine; Female; Humans; Leukopenia; Lung Neoplasms; Male; Methotrexate; Nausea; Neoplasm Metastasis; Neoplasms; Nitrosourea Compounds; Ovarian Neoplasms; Stomach Neoplasms; Vomiting | 1972 |
Cecal necrosis and perforation with systemic chemotherapy.
Topics: Adult; Asparaginase; Breast Neoplasms; Cecal Diseases; Child; Cytarabine; Daunorubicin; Female; Fluorouracil; Humans; Intestinal Perforation; Leukemia; Male; Mercaptopurine; Methotrexate; Middle Aged; Necrosis; Prednisone; Thioguanine; Vincristine | 1973 |
Status and perspectives in chemotherapy of Hodgkin's disease.
Topics: Animals; Antineoplastic Agents; Benzoates; Breast Neoplasms; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Evaluation Studies as Topic; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Mechlorethamine; Mice; Mitosis; Prednisone; Procarbazine; Remission, Spontaneous; Vincristine | 1973 |
Multiple drug therapy for disseminated malignant tumours.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Child; Cyclophosphamide; Cytarabine; Dactinomycin; Drug Synergism; Female; Fluorouracil; Humans; Leukocyte Count; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasms; Remission, Spontaneous; Urinary Bladder Neoplasms; Vincristine | 1971 |
New approaches in administration of anticancer drugs.
Topics: Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Cytarabine; Female; Fluorouracil; Humans; Lung Neoplasms; Mercaptopurine; Methotrexate; Neoplasms; Prognosis; Time Factors | 1969 |
A clinical evaluation of a prolonged schedule of cytosine arabinoside (NSC63878).
Topics: Adenocarcinoma; Blood Cells; Bone Marrow; Breast Neoplasms; Carcinoma; Colonic Neoplasms; Cytarabine; Female; Hematopoiesis; Humans; Leiomyosarcoma; Leukocyte Count; Liver; Lung Neoplasms; Melanoma; Neoplasm Metastasis; Neoplasms; Pancreatic Neoplasms; Sarcoma; Ureteral Neoplasms; Urethral Neoplasms | 1970 |